Vascularity index as a novel parameter for the in vivo assessment of angiogenesis in patients with cervical carcinoma
- PMID: 10091738
- DOI: 10.1002/(sici)1097-0142(19990201)85:3<651::aid-cncr15>3.0.co;2-9
Vascularity index as a novel parameter for the in vivo assessment of angiogenesis in patients with cervical carcinoma
Abstract
Background: The importance of angiogenesis now is well recognized. Conventionally, tumor angiogenesis is assessed by determination of microvessel density (MVD) in the surgical specimen. This study examines tumor angiogenesis using power Doppler ultrasound and a quantitative image processing system. The authors hope to develop an in vivo and noninvasive method for quantitating tumor angiogenesis.
Methods: Thirty-five patients with FIGO Stage IB-IIA cervical carcinoma exhibiting visible cervical tumors by transvaginal ultrasound were included in this study. All patients underwent radical abdominal hysterectomy and pelvic lymph node dissection. Transvaginal power Doppler ultrasound was performed before surgery to search for blood flow signals from the tumor. The intratumoral vascularity index (VI) and resistance index (RI) were calculated. The VI was defined as the number of colored pixels divided by the number of total pixels in the defined tumor section. Maximal VI and minimal RI of a certain tumor were used for analysis. Clinical and pathologic data also were recorded. The MVD of the excised tumor was assessed immunohistochemically using a monoclonal antibody against CD34.
Results: Significantly higher VI values were noted in Stage II tumors compared with Stage 1 tumors (19.01+/-10.90% vs. 9.09+/-6.59%; P = 0.008), tumors invad-ing+/-50% of the cervical stroma compared with tumors invading < 50% of the cervical stroma (13.20+/-8.20% vs. 5.72+/-5.00%; P = 0.003), tumors with lymphovascular emboli compared with tumors without lymphovascular emboli (17.28+/-8.26% vs. 6.98 +/- 5.09%; P = 0.001), and tumors with pelvic lymph node metastases compared with tumors without pelvic lymph node metastases (26.16+/-7.88% vs. 8.00+/-4.95%; P = 0.021). None of the variables mentioned earlier showed a significant difference in terms of the RI values. No correlation was noted between intratumoral RI and VI in respective tumors (P = 0.53). Analysis of VI revealed linear regression with regard to tumor size (P < 0.001, correlation coefficient [r] = 0.586) and depth of stromal invasion (P = 0.002, r = 0.497). In addition, the MVD exhibited a linear relation with VI (P = 0.006, r = 0.454), tumor size (P = 0.005, r = 0.465), and depth of stromal invasion (P = 0.009, r = 0.436) using simple regression analysis. No correlation could be found between MVD and RI.
Conclusions: In cervical carcinoma, intratumoral VI assessment by power Doppler ultrasound and quantitative image processing system showed better correlation with tumor stage, tumor size, and pathologic findings including depth of stromal invasion, lymphovascular emboli, and pelvic lymph node metastases than intratumoral RI. The in vivo indicator of angiogenic activity (VI) is well correlated with the conventional indicator of tumor angiogenic activity (MVD). Thus, VI could be a useful parameter for the in vivo assessment of global tumor angiogenesis.
Similar articles
-
The possible use of colour flow Doppler in planning treatment in early invasive carcinoma of the cervix.Br J Obstet Gynaecol. 1999 Nov;106(11):1137-42. doi: 10.1111/j.1471-0528.1999.tb08138.x. Br J Obstet Gynaecol. 1999. PMID: 10549957
-
Clinical significance of intratumoral blood flow in cervical carcinoma assessed by color Doppler ultrasound.Cancer. 1995 May 15;75(10):2518-22. doi: 10.1002/1097-0142(19950515)75:10<2518::aid-cncr2820751018>3.0.co;2-a. Cancer. 1995. PMID: 7736396
-
Comparison between 'in vivo' and 'in vitro' methods for evaluating tumor angiogenesis using cervical carcinoma as a model.Angiogenesis. 1999;3(4):295-304. doi: 10.1023/a:1026575725754. Angiogenesis. 1999. PMID: 14517409
-
Angiogenesis in malignancies of the female genital tract.Gynecol Oncol. 1999 Feb;72(2):220-31. doi: 10.1006/gyno.1998.5152. Gynecol Oncol. 1999. PMID: 10021305 Review.
-
Measurement of tumor size in early cervical cancer: an ever-evolving paradigm.Int J Gynecol Cancer. 2020 Aug;30(8):1215-1223. doi: 10.1136/ijgc-2020-001436. Epub 2020 Jul 6. Int J Gynecol Cancer. 2020. PMID: 32636272 Review.
Cited by
-
Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen.J Clin Invest. 2001 Sep;108(5):669-78. doi: 10.1172/JCI12346. J Clin Invest. 2001. PMID: 11544272 Free PMC article.
-
Association of color Doppler vascularity index and microvessel density with survival in patients with gastric cancer.Ann Surg. 2002 Apr;235(4):512-8. doi: 10.1097/00000658-200204000-00009. Ann Surg. 2002. PMID: 11923607 Free PMC article.
-
Neoangiogenesis in early cervical cancer: correlation between color Doppler findings and risk factors. A prospective observational study.World J Surg Oncol. 2008 Nov 25;6:126. doi: 10.1186/1477-7819-6-126. World J Surg Oncol. 2008. PMID: 19032773 Free PMC article.
-
Power Doppler ultrasound and contrast-enhanced ultrasound demonstrate non-invasive tumour vascular response to anti-vascular therapy in canine cancer patients.Sci Rep. 2019 Jun 25;9(1):9262. doi: 10.1038/s41598-019-45682-2. Sci Rep. 2019. PMID: 31239493 Free PMC article.
-
Assessment of cervical vascularization density in patients with locally advanced squamous cell cervical carcinoma evaluated in colour Doppler and power Doppler functions.Arch Gynecol Obstet. 2022 Apr;305(4):955-961. doi: 10.1007/s00404-021-06161-0. Epub 2021 Sep 29. Arch Gynecol Obstet. 2022. PMID: 34586470 Free PMC article.